By: Shannon Persad
Share This Post
New Jersey Opioid Overdose Deaths Decreased by 3% in 2019
New Jersey has had its fair share in the opioid epidemic, as its one of the most stricken states for the crisis.
However, for the first time, there is a decrease in opioid overdose deaths.
The Department of Law & Public Safety from the Office of the Attorney General at NJCares.gov has released preliminary statistics of the overdose deaths, naloxone administrations, and opioid prescriptions.
In 2018, there were 3,118 overdose deaths, 16,082 naloxone administrations, and 4,266,645 opioid prescriptions. Each category reduced 3%, 6%, and 6.9%.
This is great news, as New Jersey as seen improvements amidst the opioid crisis.
New Jersey’s Initiatives to Fight Opioid Crisis
In New Jersey, there are countless efforts to fight the opioid epidemic, as it got worse both in the state and in the nation.
Governor Murphy highlighted the achievements of his administration that contributed to help the cause.
According to NJBiz:
“To end this scourge, my Administration is guided by a collaborative, comprehensive, and multi-pronged approach across several departments and agencies. We have invested $100 million in each of our first two budgets in order to increase availability of medication-assisted treatment, provide greater access to Naloxone, enhance education and outreach efforts, and strengthen social supports for housing and employment. Today’s data gives us confidence that the targeted, evidence-based, and data-driven whole-of-government approach we are taking is making progress in our fight to end the opioid crisis in New Jersey,” said Murphy.”
Just last month, New Jersey was given a $1.67 million grant to distribute to 12 counties, helping different programs.
In September, New Jersey also received $7.4 million to boost its prescription monitoring program and opioid dashboard.
Get Help for Opioid Addiction
If New Jersey can see an improvement, so can you.
If you or someone you know is suffering from opioid addiction, or any other drug, contact ATSI at 1-(855)-498-2121 for a confidential consultation.